This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sempere, L. F. Articles by Cole, C. N. Search for Related Content PubMed PubMed Citation Articles by Sempere, L. F. Articles by Cole, C. N.

Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer

Departments of ¹ Biochemistry, ² Pathology, and ³ Genetics, Dartmouth Medical School, Hanover, New Hampshire; ⁴ Wilhelm Johannsen Centre for Functional Genome Research, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark; ⁵ Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; and ⁶ Santaris Pharma, Hørsholm, Denmark

Requests for reprints: Lorenzo F. Sempere, Department of Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03766. Phone: 603-653-9936; Fax: 603-653-9952; E-mail: Lorenzo.F.Sempere{at}dartmouth.edu.

MicroRNAs (miRNAs) are a new class of short noncoding regulatory RNAs (18–25 nucleotides) that are involved in diverse developmental and pathologic processes. Altered miRNA expression has been associated with several types of human cancer. However, most studies did not establish whether miRNA expression changes occurred within cells undergoing malignant transformation. To obtain insight into miRNA deregulation in breast cancer, we implemented an in situ hybridization (ISH) method to reveal the spatial distribution of miRNA expression in archived formalin-fixed, paraffin-embedded specimens representing normal and tumor tissue from >100 patient cases. Here, we report that expression of miR-145 and miR-205 was restricted to the myoepithelial/basal cell compartment of normal mammary ducts and lobules, whereas their accumulation was reduced or completely eliminated in matching tumor specimens. Conversely, expression of other miRNAs was detected at varying levels predominantly within luminal epithelial cells in normal tissue; expression of miR-21 was frequently increased, whereas that of let-7a was decreased in malignant cells. We also analyzed the association of miRNA expression with that of epithelial markers; prognostic indicators such as estrogen receptor, progesterone receptor, and HER2; as well as clinical outcome data. This ISH approach provides a more direct and informative assessment of how altered miRNA expression contributes to breast carcinogenesis compared with miRNA expression profiling in gross tissue biopsies. Most significantly, early manifestation of altered miR-145 expression in atypical hyperplasia and carcinoma in situ lesions suggests that this miRNA may have a potential clinical application as a novel biomarker for early detection. [Cancer Res 2007;67(24):11612–20]

This article has been cited by other articles:

				N. Kondo, T. Toyama, H. Sugiura, Y. Fujii, and H. Yamashita miR-206 Expression Is Down-regulated in Estrogen Receptor {alpha}-Positive Human Breast Cancer Cancer Res., July 1, 2008; 68(13): 5004 - 5008. [Abstract] [Full Text] [PDF]